Jenner & Block

The Chicago office is involved in many high-profile litigation and investigation matters and is proud of its many substantial successes.  Among recent successes:

  • Representing firm Chairman Anton R. Valukas in his capacity as Court-appointed examiner in the Lehman Brothers bankruptcy, the largest bankruptcy in the history of the United States.
  • Winning a US$101 million verdict for client Ventas, Inc. in a case arising out of Ventas’ acquisition of a publicly traded healthcare REIT, an award that was affirmed on appeal in a ruling that also reversed and remanded the district court’s decision precluding Ventas from seeking punitive damages.  After our victory, the punitive damage claim settled, bringing the total recovery to US$227 million.
  • Winning a US$272 million victory in a long-running case where we have been representing the Chapter 7 bankruptcy trustee for Emerald Casino.  A judge ruled, and then reaffirmed, that six former casino officer and director defendants breached an agreement with Emerald by failing to comply with Illinois gaming regulations.
  • Turning away attacks on client Nuveen Investments by an activist investment fund and its various affiliates that brought breach of fiduciary duty claims on behalf of a class of investors. The plaintiffs asked for US$68 million but received US$0 when the judge dismissed the case.
  • Winning two separate jury trials for client Olin Corp in insurance disputes relating to environmental cleanup costs at several sites resulting in awards that exceeded US$85 million.
  • Winning a complete defense victory in federal court in Iowa for client Duroc LLC, formerly known as Bush Hog LLC, when a jury ruled that Duroc did not infringe Deere & Co.’s patent covering rotary cutters and that the patent was invalid.
  • Winning a victory for client Hospira, Inc. in a patent infringement action brought against it by The Medicines Company. The Federal Circuit Court of Appeals invalidated two patents, clearing the path for Hospira to launch a generic version of the popular anti-coagulant drug, Angiomax.
  • Winning a US Supreme Court victory for client Wellness International Network.  In siding with arguments made by the Chicago-based team, the Court clarified a constitutional question over the authority of the nation’s nearly 1,000 federal bankruptcy judges and federal magistrate judges.
  • Winning a US$61.7 million verdict for client Dow Chemical in a patent infringement case involving a tremendously successful product line and successfully invalidating a competitor’s patent in another patent infringement matter, on behalf of a client that is a global leader in the supply of cellulose, fibrous and plastic foodstuff casings to commercial meat manufacturers and other food processors.
  • Successfully representing power supplier Energy Northwest in its lawsuit against the United States Department of Energy, resulting from DOE’s failure to dispose of Spent Nuclear Fuel from EN’s Columbia Generating Station near Richland, Washington.  Chicago lawyers won an award of US$56,859,345 in damages for the client -- everything EN asked for.  On appeal, the Federal Circuit affirmed US$48.7 million of the judgment.
  • Achieving an important win for global government contractor General Dynamics in a 22-year-long suit that included a contract claim and a qui tam action against it, both of which were dismissed and the dismissals upheld on appeal.

The Chicago office is also involved in some of the largest and most sophisticated corporate transactions around the world.  Among recent transactions:

  • Serving as lead issuer’s counsel in the new GM’s US$23.1 billion initial public offering in November 2010 - at the time the largest IPO in history.
  • Representing Archer Daniels Midland both in the US$1.3 billion sale of the cocoa business to Singapore-based Olam International Limited and the US$440 million sale of its global chocolate business to Cargill.
  • Representing Merge Healthcare Inc. in its US$1 billion sale to IBM.
  • Representing Hertz in its US$930 million acquisition of Donlen Corporation.
  • Representing Equity Group Investments in the $8.2 billion going-private transaction involving the Tribune Company.
  • Representing General Dynamics in a public offering of US$2.4 billion of notes.
  • Representing HHI Group Holdings, a major North American manufacturer of forged car parts, in its acquisition by private equity fund American Securities, LLC.
  • Representing Takeda Pharmaceuticals in a multi-billion split-off transaction involving TAP Pharmaceutical Products, a joint venture between Takeda and Abbott Laboratories.
  • Leading the multidisciplinary firm team that successfully represented General Motors in a highly challenging Section 363 asset sale in connection with its Chapter 11 reorganization in 2009.

Chicago

353 N. Clark Street
Chicago, IL 60654-3456
Directions
Phone: 312 222-9350
Fax: 312 527-0484